439 related articles for article (PubMed ID: 25582697)
21. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
Kan CE; Patton JT; Stark GR; Jackson MW
Cancer Res; 2007 Oct; 67(20):9862-8. PubMed ID: 17942917
[TBL] [Abstract][Full Text] [Related]
22. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
23. PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival.
Lu X; Fernando TM; Lossos C; Yusufova N; Liu F; Fontán L; Durant M; Geng H; Melnick J; Luo Y; Vega F; Moy V; Inghirami G; Nimer S; Melnick AM; Lossos IS
Blood; 2018 Nov; 132(19):2026-2039. PubMed ID: 30082494
[TBL] [Abstract][Full Text] [Related]
24. Cross-talk between Arg methylation and Ser phosphorylation modulates apoptosis signal-regulating kinase 1 activation in endothelial cells.
Chen M; Qu X; Zhang Z; Wu H; Qin X; Li F; Liu Z; Tian L; Miao J; Shu W
Mol Biol Cell; 2016 Apr; 27(8):1358-66. PubMed ID: 26912789
[TBL] [Abstract][Full Text] [Related]
25. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.
Pal S; Vishwanath SN; Erdjument-Bromage H; Tempst P; Sif S
Mol Cell Biol; 2004 Nov; 24(21):9630-45. PubMed ID: 15485929
[TBL] [Abstract][Full Text] [Related]
26. Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma.
Sloan SL; Renaldo KA; Long M; Chung JH; Courtney LE; Shilo K; Youssef Y; Schlotter S; Brown F; Klamer BG; Zhang X; Yilmaz AS; Ozer HG; Valli VE; Vaddi K; Scherle P; Alinari L; Kisseberth WC; Baiocchi RA
PLoS One; 2021; 16(5):e0250839. PubMed ID: 33989303
[TBL] [Abstract][Full Text] [Related]
27. MEP50/PRMT5 Reduces Gene Expression by Histone Arginine Methylation and this Is Reversed by PKCδ/p38δ Signaling.
Saha K; Adhikary G; Eckert RL
J Invest Dermatol; 2016 Jan; 136(1):214-224. PubMed ID: 26763441
[TBL] [Abstract][Full Text] [Related]
28. PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1.
Gao G; Dhar S; Bedford MT
Nucleic Acids Res; 2017 May; 45(8):4359-4369. PubMed ID: 28115626
[TBL] [Abstract][Full Text] [Related]
29. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
30. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.
Stopa N; Krebs JE; Shechter D
Cell Mol Life Sci; 2015 Jun; 72(11):2041-59. PubMed ID: 25662273
[TBL] [Abstract][Full Text] [Related]
31. Protein arginine methyltransferase 5 catalyzes substrate dimethylation in a distributive fashion.
Wang M; Fuhrmann J; Thompson PR
Biochemistry; 2014 Dec; 53(50):7884-92. PubMed ID: 25485739
[TBL] [Abstract][Full Text] [Related]
32. Protein arginine-methyltransferase-dependent oncogenesis.
Cheung N; Chan LC; Thompson A; Cleary ML; So CW
Nat Cell Biol; 2007 Oct; 9(10):1208-15. PubMed ID: 17891136
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes.
Sasaki R; Narisawa-Saito M; Yugawa T; Fujita M; Tashiro H; Katabuchi H; Kiyono T
Carcinogenesis; 2009 Mar; 30(3):423-31. PubMed ID: 19126650
[TBL] [Abstract][Full Text] [Related]
34. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
[TBL] [Abstract][Full Text] [Related]
35. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
[TBL] [Abstract][Full Text] [Related]
36. Methylosome protein 50 promotes androgen- and estrogen-independent tumorigenesis.
Wei TY; Hsia JY; Chiu SC; Su LJ; Juan CC; Lee YC; Chen JM; Chou HY; Huang JY; Huang HM; Yu CT
Cell Signal; 2014 Dec; 26(12):2940-50. PubMed ID: 25277535
[TBL] [Abstract][Full Text] [Related]
37. PRMT5 Promotes Human Lung Cancer Cell Apoptosis via Akt/Gsk3β Signaling Induced by Resveratrol.
Li Y; Yang Y; Liu X; Long Y; Zheng Y
Cell Transplant; 2019 Dec; 28(12):1664-1673. PubMed ID: 31665911
[TBL] [Abstract][Full Text] [Related]
38. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
39. MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression.
Sun Y; Jin X; Meng J; Guo F; Chen T; Zhao X; Wu H; Ren D
EMBO J; 2023 Dec; 42(23):e114558. PubMed ID: 37905571
[TBL] [Abstract][Full Text] [Related]
40. Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.
Hartley AV; Wang B; Jiang G; Wei H; Sun M; Prabhu L; Martin M; Safa A; Sun S; Liu Y; Lu T
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]